Text

optumrx logo

Text
webinar

Big Savings for Biosimilars?

Warning: Discounts in mirror may be smaller than they appear.

Text

Length | 30 minutes 

Text

As costs for complex new biologic specialty drugs continue to soar, insurers, PBM’s and other payers are looking to biosimilars for price relief. Many hope that biosimilars will provide less-expensive versions of branded biologic drugs in the same way generic drugs do for small-molecule chemical drugs.

Watch this on-demand webinar and hear from experts on the current state of biosimilars, what’s coming to the market and some of the challenges in store.

Horizontal Rule

SPEAKERS

Text

headshot of Michael Zeglinski

Text

Michael Zeglinski, R.Ph.,
Sr. Vice President,
Specialty Pharmacy

Text

headshot of Farrah Wong >

Text

Farrah Wong, Pharm.D.,
Director,
Pipeline & Drug Surveillance

Text

consultant on phone

Please complete the form to access the webinar recording

Start
* required
First Name:*
Last Name:*
Title:*
Organization:*
Email:*